BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 16087720)

  • 1. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
    Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
    J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure.
    Kooptiwut S; Zraika S; Thorburn AW; Dunlop ME; Darwiche R; Kay TW; Proietto J; Andrikopoulos S
    Endocrinology; 2002 Jun; 143(6):2085-92. PubMed ID: 12021173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets.
    Weinhaus AJ; Stout LE; Sorenson RL
    Endocrinology; 1996 May; 137(5):1640-9. PubMed ID: 8612496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets.
    Zraika S; Aston-Mourney K; Laybutt DR; Kebede M; Dunlop ME; Proietto J; Andrikopoulos S
    Diabetologia; 2006 Jun; 49(6):1254-63. PubMed ID: 16570159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture.
    Liang Y; Najafi H; Smith RM; Zimmerman EC; Magnuson MA; Tal M; Matschinsky FM
    Diabetes; 1992 Jul; 41(7):792-806. PubMed ID: 1612193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase.
    Park C; Kim JR; Shim JK; Kang BS; Park YG; Nam KS; Lee YC; Kim CH
    Arch Biochem Biophys; 1999 Feb; 362(2):217-24. PubMed ID: 9989930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhibition of specific alterations in activities and mRNA levels of rat islet glycolytic and mitochondrial enzymes in three different in vitro model systems for attenuated insulin release.
    Svensson C; Welsh N; Krawetz SA; Welsh M
    Diabetes; 1991 Jun; 40(6):771-6. PubMed ID: 1645683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Islet Glucokinase, Glucose Metabolism, and Insulin Pathway in the Enhancing Effect of Islet Neogenesis-Associated Protein on Glucose-Induced Insulin Secretion.
    Maiztegui B; Román CL; Barbosa-Sampaio HC; Boschero AC; Gagliardino JJ
    Pancreas; 2015 Aug; 44(6):959-66. PubMed ID: 25906449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products downregulate glucokinase in mice.
    Jung H; Joo J; Jeon Y; Lee J; In J; Kim D; Kang E; Kim Y; Lim Y; Kang J; Choi J
    Diabetes Metab Res Rev; 2011 Sep; 27(6):557-63. PubMed ID: 21538775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose regulates glucokinase activity in cultured islets from rat pancreas.
    Liang Y; Najafi H; Matschinsky FM
    J Biol Chem; 1990 Oct; 265(28):16863-6. PubMed ID: 2211598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents.
    Liang Y; Bonner-Weir S; Wu YJ; Berdanier CD; Berner DK; Efrat S; Matschinsky FM
    J Clin Invest; 1994 Jun; 93(6):2473-81. PubMed ID: 8200983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glucose-stimulated insulin release by pseudo-alpha-DL-glucose as a glucokinase inhibitor.
    Miwa I; Hara H; Okuda J; Suami T; Ogawa S
    Biochem Int; 1985 Dec; 11(6):809-16. PubMed ID: 3911958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity.
    Radu RG; Fujimoto S; Mukai E; Takehiro M; Shimono D; Nabe K; Shimodahira M; Kominato R; Aramaki Y; Nishi Y; Funakoshi S; Yamada Y; Seino Y
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E365-71. PubMed ID: 15479952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes.
    Cockburn BN; Ostrega DM; Sturis J; Kubstrup C; Polonsky KS; Bell GI
    Diabetes; 1997 Sep; 46(9):1434-9. PubMed ID: 9287043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucosamine-induced beta-cell dysfunction: a possible involvement of glucokinase or glucose-transporter type 2.
    Yoshikawa H; Tajiri Y; Sako Y; Hashimato T; Umeda F; Nawata H
    Pancreas; 2002 Apr; 24(3):228-34. PubMed ID: 11893929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.